Development and testing of new cytotoxic agents, multimodality treatment, cancer prevention strategies including use of biomarkers.
Wide-ranging preclinical programs in the areas of breast, ovarian, pancreatic, brain, lung, and prostate cancers, and melanoma.
Awards and Accomplishments
Notable honors received by Division of Hematology and Medical Oncology faculty.
Work published by members of the Hematology and Medical Oncology division.